Belatacept for Renal Transplant Recipients With Delayed Graft Function

Status Terminated

Clinical Trial Summary

Currently looking for individuals that have received a kidney transplant, are experiencing delayed graft function (DGF), and meet the criteria for study participation.

Clinical Trial Description

Patients who undergo kidney transplantation require long term immunosuppressive therapy (therapy that reduces your body's ability to respond to anything foreign) to prevent damage to the graft, and some experience delayed graft function (DGF, a condition in which the transplanted kidney does not function properly) after transplantation. This study is being conducted to determine if kidney transplant recipients with delayed graft function (DGF) who are switched to the immunosuppressive regimen of belatacept with mycophenolate and steroid will recover from delayed graft function (DGF) in less time (which could potentially lower the risk of rejection associated with delayed graft function) than kidney transplant recipients with delayed graft function (DGF) who remain on the current standard immunosuppressive regimen (standard of care). ;

Study Design

Related Conditions & MeSH terms

Delayed Graft Function

Clinical Trial Details

NCT number	NCT02134288
Study type	Interventional
Source	Ohio State University
Contact
Status	Terminated
Phase	Early Phase 1
Start date	April 2014
Completion date	January 18, 2019

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT02312115` - Delayed Renal Allograft Function and Furosemide Treatment	Phase 2
Completed	`NCT02134314` - C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI	Phase 1/Phase 2
Completed	`NCT02346968` - Evaluation of CAF22 After Renal Transplantation
Completed	`NCT01794663` - Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function	Phase 2
Completed	`NCT00298181` - YSPSL for Prevention of Delayed Graft Function Part A	Phase 1/Phase 2
Not yet recruiting	`NCT05166460` - Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation	N/A
Recruiting	`NCT03071536` - Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation	N/A
Not yet recruiting	`NCT05513807` - Graft Acute Kidney Injury: Vitamin B3 to Facilitate Renal Recovery In the Early Life of a Transplant	Phase 3
Recruiting	`NCT04005469` - Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation	Phase 1/Phase 2
Completed	`NCT01848249` - Deceased Donor Biomarkers and Recipient Outcomes
Active, not recruiting	`NCT02474667` - Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney	Phase 3
No longer available	`NCT02026934` - CliniMACS® CD34+ Reagent System for Expanded Access Use	N/A
Terminated	`NCT00217152` - A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors	Phase 4
Recruiting	`NCT05430620` - Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys	Phase 3
Completed	`NCT03864926` - Envarsus in Delayed Graft Function (E-DGF)	Phase 4
Recruiting	`NCT06367205` - Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations	N/A
Completed	`NCT02610296` - QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant	Phase 3
Active, not recruiting	`NCT02568696` - Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function
Recruiting	`NCT01837043` - Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function	Phase 2
Terminated	`NCT01878786` - A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys	Phase 2/Phase 3